Afya Ltd (AFYA)

Currency in USD
13.84
+0.43(+3.21%)
Closed·
13.840.00(0.00%)
·
High dividend Yield
AFYA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
13.3313.91
52 wk Range
13.0016.50
Key Statistics
Prev. Close
13.41
Open
13.4
Day's Range
13.33-13.91
52 wk Range
13-16.5
Volume
174.97K
Average Volume (3m)
103.96K
1-Year Change
-8.1009%
Book Value / Share
10.19
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AFYA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
16.70
Upside
+20.69%
Members' Sentiments
Bearish
Bullish
ProTips
Management has been aggressively buying back shares

Afya Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Analyst Ratings

1 Buy
5 Hold
3 Sell
Ratings:
9 analysts
Overall Consensus
Sell

Analysts 12-Month Price Target:

Average 16.70
(+20.69% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
JPMorgan
Hold21.00+51.73%21.50MaintainJun 22, 2026
BofA Securities
Hold18.00+30.06%17.00MaintainJun 11, 2026
JPMorgan
Hold21.50+55.35%22.00MaintainApr 30, 2026
BofA Securities
Hold17.00+22.83%22.00DowngradeFeb 24, 2026
Morgan Stanley
Sell16.00+15.61%17.50DowngradeFeb 13, 2026

Afya Ltd Earnings Call Summary for Q2/2026

  • Afya posted Q2 revenue up 6% to BRL 972M and H1 revenue up 7% to BRL 1,985M, with net income rising 14% in Q2 despite margin pressure.
  • Adjusted EBITDA margins fell 190 bps to 46.2% in H1 as company increased spending on continuing education and medical practice solutions.
  • Company returned BRL 448M to shareholders in H1 via dividends and buybacks, exceeding free cash flow, while reducing net debt to 0.8x EBITDA.
  • Management reaffirmed FY2026 guidance of BRL 1.7-1.8B adjusted EBITDA, expects H2 CapEx acceleration to fund product enhancements.
  • Shares fell 2.4% to $13.41, near 52-week low, as investors weighed solid growth against investment-driven margin compression and AI competition.
Last Updated: 2026/08/14, 01:02
Read Full Transcript

Earnings

Latest Release
Aug 13, 2026
EPS / Forecast
2,21 / 2,08
Revenue / Forecast
972,1M / 1B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 8.20%
Dividend Yield
4.90%
Industry Median 1.85%
Annualised payout
0.66
Paid annually
5-Years Growth
-
Growth Streak

AFYA Income Statement

Compare AFYA to Peers and Sector

Metrics to compare
AFYA
Peers
Sector
Relationship
P/E Ratio
8.4x8.8x10.3x
PEG Ratio
0.890.770.02
Price/Book
1.3x1.6x1.4x
Price / LTM Sales
1.7x1.0x0.9x
Upside (Analyst Target)
23.1%34.6%26.3%
Fair Value Upside
Unlock35.9%12.0%Unlock

Afya Limited operates as a medical education group in Brazil. The company operates in three segments: Undergraduate, Continuing Education, and Medical Practice Solutions. The Undergraduate segment offers educational services through undergraduate courses related to medical school, health sciences, and other non-health undergraduate programs, including medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, biomedicine, business administration, accounting, law, civil and industrial engineering, and pedagogy. The Continuing Education segment provides medical education, including residency preparation programs, specialization test preparation, graduate courses in medicine, and digital and in-person professional development for physicians and medical students. The Medical Practice Solutions segment offers clinical decision support platforms, medical practice management software, healthcare financial services, and digital healthcare ecosystem solutions, such as electronic medical records, practice management tools, telemedicine, digital prescriptions, and doctor-patient relationship platforms. This segment also provides a subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. The company also offers educational health and medical imaging; and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. In addition, it offers printed and digital content, as well as an online medical education platform and physicians, healthcare professionals and students. Afya Limited was founded in 1999 and is headquartered in Belo Horizonte, Brazil.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
5,95M6,69%81,82M
Other Institutional Investors
105,38M93,31%1,45B
Public Companies & Retail Investors
0,000,00%0,00
Total
111,34M100,00%1,53B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Headline68,62%61 076 080839 185
Bertelsmann SE & Co. KGaA38,28%34 074 134468 179

FAQ

What Is the Afya (AFYA) Stock Price Today?

The Afya stock price today is 13,84 USD.

What Stock Exchange Does Afya Trade On?

Afya is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Afya?

The stock symbol for Afya is "AFYA."

Does Afya Pay Dividends? What’s The Current Dividend Yield?

The Afya dividend yield is 4.78%.

What Is the Afya Market Cap?

As of today, Afya market cap is 1,19B USD.

What Is Afya's Earnings Per Share (TTM)?

The Afya EPS (TTM) is 8,20.

When Is the Next Afya Earnings Date?

Afya will release its next earnings report on Nov 12, 2026.

From a Technical Analysis Perspective, Is AFYA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Afya Stock Split?

Afya has split 0 times.

How Many Employees Does Afya Have?

Afya has 9395 employees.

What is the current trading status of Afya (AFYA)?

As of Aug 15, 2026, Afya (AFYA) is trading at a price of 13,84 USD, with a previous close of 13,41 USD. The stock has fluctuated within a day range of 13,33 USD to 13,91 USD, while its 52-week range spans from 13,00 USD to 16,50 USD.

What Is Afya (AFYA) Price Target According to Analysts?

The average 12-month price target for Afya is 16,70 USD, with a high estimate of 20.59181121 USD and a low estimate of 14.2182288 USD. 1 analysts recommend buying the stock, while 3 suggest selling, leading to an overall rating of Sell. The stock has an +20,69% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.